glp-1 constipation lawsuit in west virginia A class-action has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster drug to treat obesity. When the major pharmacy benefit manager informed patients semaglutide intestinal paralysis class action
Description
compounding pharmacies and dispenses the base form, not salt forms
For 503A pharmacies, the FDA confirmed a narrow enforcement safe harbor: the agency does not currently intend to take action against pharmacies that compound an essentially-a-copy GLP-1 product, provided they fill no more than four prescriptions of that preparation per calendar month
It is a clinical requirement
Other symptoms include fatigue, vision changes, numbness, dry skin, slow wound healing, and infections
